Ultragenyx Pharmaceutical Inc. buy Wells Fargo & Company
Start price
20.12.24
/
50%
€41.80
Target price
20.12.25
€84.54
Performance (%)
-32.06%
End price
21.12.25
€28.40
Summary
This prediction ended on 21.12.25 with a price of €28.40. Massive losses of -32.06% were the result for the BUY prediction by Wells_Fargo___Compan. Wells_Fargo___Compan has a follow-up prediction for Ultragenyx Pharmaceutical Inc. where he still thinks Ultragenyx Pharmaceutical Inc. is a Buy. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 0.690% | 0.690% | -29.808% |
| iShares Core DAX® | 1.732% | 4.638% | 21.634% |
| iShares Nasdaq 100 | 3.304% | 0.517% | 5.422% |
| iShares Nikkei 225® | 2.342% | 0.972% | 15.333% |
| iShares S&P 500 | 2.357% | 0.872% | 3.125% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its price target raised by analysts at Wells Fargo & Company from $75.00 to $88.00. They now have an "overweight" rating on the stock.
Ratings data for RARE provided by MarketBeat
In the thread Trading Ultragenyx Pharmaceutical Inc.
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten
Current prediction by Wells_Fargo___Compan for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€26.00
10.07.25
10.07.25
€55.35
10.07.26
10.07.26
11.54%
23.12.25
23.12.25
Stopped prediction by Wells_Fargo___Compan for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€29.20
20.10.25
20.10.25
€55.74
20.10.26
20.10.26
-0.68%
23.12.25
23.12.25
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€46.20
02.08.24
02.08.24
€68.71
02.08.25
02.08.25
-46.75%
03.08.25
03.08.25
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€37.60
08.12.23
08.12.23
€66.97
08.12.24
08.12.24
23.94%
09.12.24
09.12.24

